The director of the Montefiore Headache Center will provide further insight into migraine care at the 1st Annual International Congress on the Future of Neurology, to be held September 27-28 in New York City.
Richard Lipton, MD
Advertisement
Articles by Richard Lipton, MD
The director of the Montefiore Headache Center and professor of neurology at Albert Einstein College of Medicine spoke about the results of an analysis of eptinezumab’s effect on the severity of migraine and its impact on patients’ lives.
Advertisement
Latest Updated Articles
Richard Lipton, MD: Eptinezumab Maintains Reductions in the Impact of MigrainePublished: July 13th 2019 | Updated:
Richard Lipton, MD: Interpreting Eptinezumab's Impact on HIT-6 ScorePublished: September 9th 2019 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Earlier Initiation of Pimavanserin Leads to Better Improvement of Parkinson Disease Psychosis Symptoms
2
MDS Congress 2025: Top Expert Interviews and Key Takeaways
3
Increasing Early Awareness of Child Neurology as a Potential Career Path: Miya Bernson-Leung, MD, EdM
4
A Step Forward in Multiple System Atrophy: Phase 2 Findings Reinforce ATH434’s Disease-Modifying Potential
5
